KMDA

Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Peers: KNSA BHC PRGO AMRX ALKS INDV TEVA VTRS LNTH TLX

| Held by: DISV DFIS DFIC AIMS DFAX IBBQ BIB

Scroll to Statements

Index	-
Market Cap	410.75M
Enterprise Value	349.24M
Income	20.37M
Sales	181.68M
Book/sh	4.50
Cash/sh	1.27
Dividend Est.	-
Dividend TTM	0.25 (3.51%)
Dividend Ex-Date	Mar 23, 2026
Dividend Gr. 3/5Y	- -
Payout	64.45%
Employees	462
IPO	May 31, 2013

P/E	20.37
Forward P/E	11.61
PEG	0.43
P/S	2.26
P/B	1.58
P/C	5.62
P/FCF	23.73
EV/EBITDA	8.61
EV/Sales	1.92
Quick Ratio	1.90
Current Ratio	3.33
Debt/Eq	0.04
LT Debt/Eq	0.04
Option/Short	Yes / Yes

EPS (ttm)	0.35
EPS next Y	0.61
EPS next Q	0.11
EPS this Y	17.24%
EPS next Y	43.47%
EPS next 5Y	26.89%
EPS past 3/5Y	- -2.03%
Sales past 3/5Y	11.74% 6.25%
EPS Y/Y TTM	26.52%
Sales Y/Y TTM	8.64%
EPS Q/Q	3.92%
Sales Q/Q	2.78%
Earnings	May 13 BMO
EPS/Sales Surpr.	-26.78% -3.17%

Insider Own	45.48%
Insider Trans	0.00%
Inst Own	14.61%
Inst Trans	-1.68%
ROA	5.37%
ROE	7.97%
ROIC	7.58%
Gross Margin	41.16%
Oper. Margin	13.98%
Profit Margin	11.21%
SMA20	-2.69%
SMA50	-6.87%
SMA200	-7.40%
Trades

Shs Outstand	57.69M
Shs Float	31.45M
Short Float	0.36%
Short Ratio	2.49
Short Interest	0.11M
52W High	9.35 -23.85%
52W Low	6.50 9.54%
Volatility	1.33% 1.83%
ATR (14)	0.16
RSI (14)	36.85
Beta	0.88
Rel Volume	0.23
Avg Volume	45.18K
Volume	10,238

Perf Week	-5.07%
Perf Month	-1.66%
Perf Quarter	-16.33%
Perf Half Y	-9.41%
Perf YTD	0.85%
Perf Year	-11.22%
Perf 3Y	40.99%
Perf 5Y	26.02%
Perf 10Y	92.41%
Recom	1.00
Target Price	13.00
Prev Close	7.15
Price	7.12
Change	-0.42%

Date	Action	Analyst	Rating Change	Price Target Change
Mar-21-25	Initiated	The Benchmark Company	Buy	$15
Jul-03-24	Initiated	Stifel	Buy	$18
Feb-02-18	Initiated	Chardan Capital Markets	Buy	$7

Jun-01-26 07:00AM	Kamada Announces FDA Approval of its New In-House Rabies Virus Neutralization Testing Laboratory (GlobeNewswire)
May-13-26 07:01PM	Kamada Ltd (KMDA) Q1 2026 Earnings Call Highlights: Strategic Growth Amid Shipment Delays (GuruFocus.com) -6.76%
12:48PM	Kamada Ltd. Q1 2026 Earnings Call Summary (Moby)
07:13AM	Kamada: Q1 Earnings Snapshot (Associated Press)
07:00AM	Kamada Reports First Quarter 2026 Financial Results and Affirms 2026 Annual Guidance; Expecting Significantly Stronger Remainder of the Year (GlobeNewswire)
07:00AM	Loading…
May-06-26 07:00AM	Kamada to Announce First Quarter 2026 Financial Results on May 13, 2026 (GlobeNewswire)
Mar-31-26 07:00AM	Kamada Updates on Withholding Tax Procedures on Previously Announced Cash Dividend to Shareholders (GlobeNewswire)
Mar-26-26 07:00AM	Kamada Announces FDA Approval of its Plasma Collection Center in San Antonio, Texas (GlobeNewswire)
Mar-11-26 03:02PM	Kamada Ltd (KMDA) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic Outlook (GuruFocus.com)
07:23AM	Kamada: Q4 Earnings Snapshot (Associated Press Finance)
07:02AM	Kamada Reports Record Top- and Bottom-line 2025 Financial Results and Affirms 2026 Guidance Representing Continued Double-Digit Organic Profitable Growth (GlobeNewswire)
07:00AM	Kamada Declares Cash Dividend of $0.25 Per Share, to be Paid in Accordance with an Adopted Annual Cash Dividend Policy (GlobeNewswire)
Mar-10-26 09:23AM	Earnings To Watch: Kamada Ltd (KMDA) Reports Q4 2025 Result (GuruFocus.com)
Mar-06-26 09:15AM	Ahead of Kamada (KMDA) Q4 Earnings: Get Ready With Wall Street Estimates for Key Metrics (Zacks)
Mar-05-26 11:40AM	KMDA vs. ARGX: Which Stock Is the Better Value Option? (Zacks)
07:00AM	Loading…
Mar-04-26 07:00AM	Kamada to Announce Fiscal Year and Fourth Quarter 2025 Financial Results on March 11, 2026 (GlobeNewswire)
Feb-17-26 11:40AM	KMDA or TECH: Which Is the Better Value Stock Right Now? (Zacks) +6.82%
09:40AM	Are Investors Undervaluing Kamada (KMDA) Right Now? (Zacks)
Jan-27-26 08:21AM	Kamada (KMDA) Soars 8.1%: Is Further Upside Left in the Stock? (Zacks)
Jan-09-26 05:07PM	Hubspot Stock Set to Rise, Says Analyst. Plus, McGraw Hill, UHS, and More Stocks. (Barrons.com)
Jan-07-26 07:00AM	Kamada Provides 2026 Annual Guidance of $200 - $205 Million in Revenues and $50 - $53 Million of Adjusted EBITDA, Representing Double-Digit Growth and Affirms 2025 Financial Guidance (GlobeNewswire) +5.79%
Dec-18-25 07:00AM	Kamada Announces a $10-$14 Million Extension of Canadian Supply Tender (GlobeNewswire)
Dec-08-25 07:00AM	Kamada Announces Discontinuation of its Phase 3 Inhaled AAT Clinical Trial; Reiterates 2025 Full-Year Guidance and Projects Double-Digit Growth in Revenues and Profitability in 2026 (GlobeNewswire)
Nov-11-25 12:45PM	Kamada (KMDA) is an Incredible Growth Stock: 3 Reasons Why (Zacks)
Nov-10-25 04:00PM	Kamada Ltd (KMDA) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic Advancements (GuruFocus.com) +5.41%
09:30AM	Kamada (KMDA) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
08:15AM	Kamada (KMDA) Misses Q3 Earnings Estimates (Zacks)
07:00AM	Kamada Reports Strong Third Quarter and Nine Month 2025 Financial Results with over 30% Year-over-Year Profitability Growth (GlobeNewswire)
Nov-07-25 07:21AM	Earnings To Watch: Kamada Ltd (KMDA) Reports Q3 2025 Result (GuruFocus.com)
Nov-06-25 09:15AM	Countdown to Kamada (KMDA) Q3 Earnings: A Look at Estimates Beyond Revenue and EPS (Zacks)
08:25AM	Loading…
08:25AM	Regenxbio (RGNX) Reports Q3 Loss, Beats Revenue Estimates (Zacks)
Nov-05-25 10:55AM	Ocugen (OCGN) Reports Q3 Loss, Beats Revenue Estimates (Zacks)
09:40AM	Should Value Investors Buy Kamada (KMDA) Stock? (Zacks)
Nov-04-25 07:00AM	Kamada Announces First Patient Enrolled into an Investigator-Initiated Clinical Trial of CYTOGAM to Prevent Cytomegalovirus in Kidney Transplantation (GlobeNewswire)
Nov-03-25 07:00AM	Kamada to Announce Third Quarter and Nine Months Ended September 30, 2025 Financial Results on November 10, 2025 (GlobeNewswire)
Oct-31-25 12:07PM	KMDA vs. NVZMY: Which Stock Is the Better Value Option? (Zacks)
Oct-30-25 09:55AM	Wall Street Analysts Believe Kamada (KMDA) Could Rally 113.15%: Here's is How to Trade (Zacks)
Oct-29-25 07:00AM	Kamada to Present at the Stifel 2025 Healthcare Conference (GlobeNewswire)
Oct-22-25 12:45PM	3 Reasons Why Growth Investors Shouldn't Overlook Kamada (KMDA) (Zacks)
Oct-20-25 09:40AM	Are Investors Undervaluing Kamada (KMDA) Right Now? (Zacks)
Oct-15-25 11:40AM	KMDA or ILMN: Which Is the Better Value Stock Right Now? (Zacks)
Oct-14-25 09:55AM	Does Kamada (KMDA) Have the Potential to Rally 114.39% as Wall Street Analysts Expect? (Zacks)
Oct-06-25 12:45PM	Is Kamada (KMDA) a Solid Growth Stock? 3 Reasons to Think "Yes" (Zacks)
Oct-03-25 09:40AM	Should Value Investors Buy Kamada (KMDA) Stock? (Zacks)
Sep-29-25 11:40AM	KMDA vs. ILMN: Which Stock Is the Better Value Option? (Zacks)
Sep-17-25 09:40AM	Are Investors Undervaluing Kamada (KMDA) Right Now? (Zacks)
Sep-03-25 12:45PM	Kamada (KMDA) is an Incredible Growth Stock: 3 Reasons Why (Zacks)
09:55AM	Wall Street Analysts See an 110.11% Upside in Kamada (KMDA): Can the Stock Really Move This High? (Zacks)
09:15AM	Halozyme Therapeutics, Inc. (HALO) Hit a 52 Week High, Can the Run Continue? (Zacks)
Sep-02-25 07:00AM	Kamada to Participate in Upcoming September Investor Conferences (GlobeNewswire)
Sep-01-25 11:40AM	KMDA or ARGX: Which Is the Better Value Stock Right Now? (Zacks)
09:40AM	Should Value Investors Buy Kamada (KMDA) Stock? (Zacks)
Aug-18-25 12:45PM	3 Reasons Growth Investors Will Love Kamada (KMDA) (Zacks)
Aug-14-25 12:00PM	What Makes Kamada (KMDA) a New Buy Stock (Zacks)
11:40AM	KMDA vs. ILMN: Which Stock Is the Better Value Option? (Zacks)
09:40AM	Are Investors Undervaluing Kamada (KMDA) Right Now? (Zacks)
03:08AM	Kamada Ltd (KMDA) Q2 2025 Earnings Call Highlights: Strong Revenue Growth and Increased ... (GuruFocus.com)
Aug-13-25 09:30AM	Kamada (KMDA) Reports Q2 Earnings: What Key Metrics Have to Say (Zacks)
08:20AM	Kamada (KMDA) Q2 Earnings Top Estimates (Zacks)
07:00AM	Kamada Reports Strong Second Quarter and First Half 2025 Financial Results with 11% Year-Over-Year 6-Month Top Line Growth and a 35% Increase in Profitability; Raises Full-Year Profitability Guidance (GlobeNewswire)
Aug-12-25 03:00PM	Liquidia Technologies, Inc. (LQDA) Reports Q2 Loss, Beats Revenue Estimates (Zacks)
Aug-11-25 07:00AM	Kamada Announces FDA Approval of its Plasma Collection Center in Houston, Texas (GlobeNewswire)
Aug-08-25 09:15AM	Exploring Analyst Estimates for Kamada (KMDA) Q2 Earnings, Beyond Revenue and EPS (Zacks)
Aug-07-25 06:40PM	Verastem (VSTM) Reports Q2 Loss, Misses Revenue Estimates (Zacks)
Aug-06-25 07:00AM	Kamada to Announce Second Quarter and First Half Ended June 30, 2025 Financial Results on August 13, 2025 (GlobeNewswire)
Jul-04-25 11:40AM	KMDA or ACAD: Which Is the Better Value Stock Right Now? (Zacks)
09:40AM	Is Kamada (KMDA) Stock Undervalued Right Now? (Zacks)
Jun-25-25 11:14AM	Strength Seen in Kamada (KMDA): Can Its 9.5% Jump Turn into More Strength? (Zacks)
Jun-18-25 11:40AM	KMDA vs. ACAD: Which Stock Is the Better Value Option? (Zacks)
09:40AM	Should Value Investors Buy Kamada (KMDA) Stock? (Zacks)
Jun-17-25 07:00AM	Kamada Confirms Continuous Global Business Operations and Products Availability Despite Recent Events in the Middle East (GlobeNewswire)
Jun-10-25 10:21AM	Implied Volatility Surging for Kamada Stock Options (Zacks)
Jun-02-25 09:55AM	Wall Street Analysts Think Kamada (KMDA) Could Surge 106.86%: Read This Before Placing a Bet (Zacks)
09:40AM	Are Investors Undervaluing Kamada (KMDA) Right Now? (Zacks)
May-28-25 11:40AM	KMDA vs. CSLLY: Which Stock Should Value Investors Buy Now? (Zacks)
May-16-25 09:55AM	Wall Street Analysts Believe Kamada (KMDA) Could Rally 106.56%: Here's is How to Trade (Zacks)
09:40AM	Is Kamada (KMDA) Stock Undervalued Right Now? (Zacks)
May-14-25 09:30AM	Compared to Estimates, Kamada (KMDA) Q1 Earnings: A Look at Key Metrics (Zacks)
08:10AM	Kamada (KMDA) Q1 Earnings Match Estimates (Zacks)
07:00AM	Kamada Reports Strong First Quarter 2025 Financial Results with Year Over Year Top Line Growth of 17% and a 54% Increase in Profitability (GlobeNewswire)
May-13-25 08:50AM	XOMA Royalty (XOMA) Tops Q1 Earnings and Revenue Estimates (Zacks)
May-09-25 09:15AM	Kamada (KMDA) Q1 Earnings Preview: What You Should Know Beyond the Headline Estimates (Zacks)
May-08-25 05:55PM	Puma Biotech (PBYI) Q1 Earnings and Revenues Top Estimates (Zacks)
May-07-25 06:35PM	Nuvation Bio Inc. (NUVB) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
07:00AM	Kamada to Announce First Quarter 2025 Financial Results on May 14, 2025 (GlobeNewswire)
May-06-25 07:10PM	Keros Therapeutics, Inc. (KROS) Q1 Earnings and Revenues Beat Estimates (Zacks)
May-05-25 07:00AM	Kamada Announces Launch of a Comprehensive Post-Marketing Research Program for CYTOGAM (GlobeNewswire)
Mar-24-25 07:00AM	Kamada Updates on Withholding Tax Procedures on Previously Announced Special Cash Dividend to Shareholders (GlobeNewswire) +5.65%
Mar-19-25 07:00AM	Kamada Announces Expansion of Plasma Collection Operations with the Opening of New Site in San Antonio, Texas (GlobeNewswire)
Mar-18-25 09:00AM	Sidoti Events, LLC's Virtual March Small-Cap Conference (ACCESSWIRE)
Mar-05-25 07:05AM	Kamada Reports Record Top and Bottom Line 2024 Financial Results and Affirms 2025 Guidance Representing Double-Digit Profitable Growth (GlobeNewswire) +7.41%
07:00AM	Kamada Declares Special Cash Dividend of $0.20 Per Share (GlobeNewswire)
Feb-26-25 07:00AM	Kamada to Announce Fourth Quarter and Fiscal Year 2024 Financial Results on March 5, 2025 (GlobeNewswire)
Jan-23-25 07:14AM	Kamada to supply immune globulin products in Latin America (Pharmaceutical Business Review) -5.31%
Jan-22-25 07:00AM	Kamada Announces a $25 Million 3-Year Contract for Supply of KAMRAB and VARIZIG in Latin America (GlobeNewswire) +6.36%
Jan-09-25 07:29AM	Kamada Projects Double-Digit Growth for 2025, Expands Plasma Operations (TipRanks)
Jan-08-25 07:00AM	Kamada Affirms 2024 Financial Guidance and Announces Expected Continued Double-Digit Profitable Growth for 2025 (GlobeNewswire) +7.65%
Nov-13-24 07:00AM	Kamada Reports Continued Profitable Growth with Strong Third Quarter and Nine Month 2024 Financial Results; Raises Full-Year Profitability Guidance (GlobeNewswire)
Nov-06-24 07:00AM	Kamada to Announce Third Quarter and Nine-Months Ended September 30, 2024 Financial Results and Host Conference Call on November 13, 2024 (GlobeNewswire)
Nov-04-24 07:00AM	Kamada to Present at the Stifel 2024 Healthcare Conference (GlobeNewswire)

Kamada Ltd. is a biopharmaceutical company, which focuses on specialty plasma-derived therapeutic. It operates through the Proprietary Products and Distribution segments. The Proprietary Products segment covers the development, manufacture, and sale of plasma-derived protein therapeutics products. The Distribution segment covers the drug products in Israel, which are manufactured by third parties. The company was founded by David Tsur and Ralf Hahn on December 13, 1990 and is headquartered in Rehovot, Israel.

Chief Executive OfficerMr. Amir London

Chief Financial OfficerMr. Chaime Orlev

Chief Operating OfficerMr. Eran Nir

Vice President of US Commercial OperationsMr. Jon R. Knight

Vice President of Business Development & Strategic ProgramsMr. Boris Gorelik

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

Kamada Ltd

Upgrade your Finviz experience